Q2 2023 Assertio Holdings Inc Earnings Call Transcript
Good morning, and welcome to the Assertio Holdings, Inc. Second Quarter 2023 Financial Results Conference Call. (Operator Instructions). Please note, this event is being recorded. I would like to turn the conference over to Matt Kreps from Darrow Associates, Investor Relations for Assertio. Please go ahead.
Good afternoon, and thank you, everyone, for joining us today to discuss Assertio second quarter 2023 financials. The news release covering our earnings post period is now available on the Investor page of our website at investor.assertiotx.com. I would encourage you to review the release and tables in conjunction with today's discussion.
With me today are Dan Peisert, President and CEO; Paul Schwichtenberg, Senior Vice President and CFO; and Tom Riga, outgoing CEO of Spectrum Pharmaceuticals, for which we closed the acquisition earlier this week. Dan will open remarks to provide an overview of the business. Tom will provide additional comments on Spectrum's ROLVEDON progress, and Paul will review our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |